Study of Anti-HIVCellular Therapy Based on Dendritic Cells Pulsed With Chemically Inactivated Virus
|臨床試驗位址||University of Sao Paulo General Hospital|
|目前研究進度||This study has been completed.|
|試驗開始日期||May 9, 2016|
|試驗開始日期||July 20, 2016|
The aim of this study was to assess tolerability and safety of three different formulations of an anti-HIV immunotherapy based on autologous dendritic cells (DCs) pulsed with HIV chemically inactivated with Aldrithiol™-2 (AT-2). Patients were chronically infected with HIV, naïve for antiretroviral drugs. A possible immunological and virological favorable impact was also assessed.